pISSN 1226-6051
eISSN 2508-786X
eISSN 2508-786X
Comparison of alternative policies to improve drug access in Korea
Risk sharing agreement | Waiver of cost-effective analysis | Medically essential drugs | Differential coverage system |
|
---|---|---|---|---|
Time of introduction | Dec-13 | May-15 | Jul-12 | Dec-13 |
Cost-effective analysis required | O | X | X | O |
Application condition | ||||
Disease | ||||
- Cancer or rare disease | O |
O | O | X |
- Severe and incurable disease | O |
X | X | X |
Clinical necessity | ||||
-No alternative treatment option | O |
O |
O |
O |
-Severe enough to threaten life | O |
O |
O |
X |
Difficulty in generating evidence | X | O | O | X |
Clinically meaningful improvement | O | X | X | O |
Other considerations | Other considerations such as the severity of the disease, its social impact, and its impact on other health and medical care | Registered in three or more countries among A7b | Other cases where the committee deems it essential for the care of patients | Social necessity |
a Differently applied according to the degree to which each item in the application condition is applicable
b United States, United Kingdom, France, Germany, Italy, Switzerland, Japan
* Need to meet either one of two conditions
† Need to meet both of the two conditions